Has the Bubble Burst for Viking Therapeutics Stock?

The excitement surrounding Viking Therapeutics (NASDAQ: VKTX) stock has been dying down significantly lately. Many investors may have been hoping that another, larger healthcare company would acquire it for its promising GLP-1 treatment, VK2735 — but that doesn’t appear to be happening. Could Viking’s rapidly declining valuation be a sign that the bubble has burst for it, given its inflated price, or is the healthcare stock due for a big rally this year?

This article was originally published here.